Not sure if the confidence intervals for the Australian Paediatric study have been calculated and posted by anyone yet. I know a few holders were interested, and Tony mentioned them in the CC. The calculations can be worked using data in the ASX release. Unsure why they weren't included in the original release.
Cheers n1
DYOR/GLTAH
Australian Paediatric Study Results - 22 June 2017
Pneumonia (123 patients)
(cough, age, gender and symptoms)
PPA 89% (95%CI 82%-94%)
NPA 94% (95%CI 71%-86%)
Croup (57 patients)
(cough, age, gender and symptoms)
PPA 100% (95%CI 94%-100%)
NPA 96% (95%CI 88%-100%)
Primary Upper Respiratory Tract Infection (53 patients)
(cough, age, gender and symptoms)
PPA 92% (95%CI 82%-98%)
NPA 89% (95%CI 77%-96%)
Bronchiolitis (101 patients)
(cough, age, gender and symptoms)
PPA 95% (95%CI 89%-98%)
NPA 94% (95%CI 88%-98%)
Asthma/Reactive Airway Disease (234 patients)
(cough, age, gender and symptoms)
PPA 92% (95%CI 88%-95%)
NPA 89% (95%CI 84%-93%)
Lower Respiratory Tract Involvement (492 patients)
(cough, age, gender and symptoms)
PPA 90% (95%CI 87%-93%)
NPA 92% (95%CI 89%-94%)
Math problem with results, page-214
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #